Selskabets formål er handel - herunder eksport, import - produktion samt anden i forbindelse hermed stående virksomhed, bl.a. restaurationsvirksomhed
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 486.7 mio. | 32.3 mio. | 405.3 mio. | 143.3 mio. | 440 | |
CVR: 67303016
Secondary names: AIR NORTH ApS, DANHEKO ApS, FITNESS PARTNER ApS
4 properties
Upgrade to Pro to see addresses, building data and ownership details
Sven Moesgaard left the board
Compared to 164 companies in Fremstilling af andre fødevarer i.a.n.
Comparison is based on industry median values
Companies in the same industry and area
PHARMA NORD ApS demonstrates a stable financial health with a notable increase in revenue, reaching 486.7 million DKK in 2024, up from 447.4 million DKK in 2023. However, profit has fluctuated, decreasing to 32.3 million DKK in 2024 from 23.3 million DKK the previous year, indicating potential concerns regarding profit margins. The company's equity has also declined from 183 million DKK in 2022 to 143.3 million DKK in 2024, suggesting a weakening financial position. Overall, while revenue growth is a positive sign, the declining profit and equity levels warrant close monitoring, especially in a competitive food manufacturing industry.
AI-generated summary
companydata.dk